Blaine Labs Inc FDA Record
- Latest inspection OAI · Dec 22, 2025
- 2 Class I recalls
- Last warning letter 2020
Blaine Labs Inc has 9 FDA recalls (2 Class I), 8 inspections, 1 510(k) clearance and 1 compliance action on record. FDA has issued 1 warning letter to Blaine Labs Inc, the most recent on May 5, 2020.
- Latest recall
- D-0699-2026 · Class II · Apr 8, 2026
- Latest inspection
- Dec 22, 2025 · OAI
- Latest 510(k)
- Jul 25, 2000
Summary
| Records | Count | Last refreshed | Source as of | Status |
|---|---|---|---|---|
| Recalls | 9 (2 Class I) | Nov 15, 2026 | File dated Nov 10, 2026 | Current |
| 510(k) clearances | 1 | Nov 15, 2026 | File dated Nov 9, 2026 | Current |
| Inspections | 8 | Nov 17, 2026 | Newest record Nov 9, 2026 | Current |
| Compliance actions | 1 | Nov 2, 2026 | Newest record Oct 29, 2026 | Current |
FDA record by year
Blaine Labs Inc: FDA inspections per year
| Year | Inspections | OAI | Warning letters | Recall records | Class I |
|---|---|---|---|---|---|
| 2026 | 0 | 0 | 0 | 8 | 1 |
| 2025 | 1 | 1 | 0 | 0 | 0 |
| 2024 | 0 | 0 | 0 | 0 | 0 |
| 2023 | 1 | 1 | 0 | 0 | 0 |
| 2022 | 0 | 0 | 0 | 1 | 1 |
| 2021 | 1 | 1 | 0 | 0 | 0 |
| 2020 | 0 | 0 | 1 | 0 | 0 |
| 2019 | 0 | 0 | 0 | 0 | 0 |
| 2018 | 0 | 0 | 0 | 0 | 0 |
| 2017 | 0 | 0 | 0 | 0 | 0 |
Reviewing Blaine Labs Inc as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.
Or check Blaine Labs Inc yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.
Blaine Labs Inc FDA Warning Letters
| Issued | Subject | Issuing office | Close-out letter |
|---|---|---|---|
| May 5, 2020 · Letter on fda.gov | Division of Pharmaceutical Quality Operations IV |
Recent recalls
| Number | Class | Product | Date |
|---|---|---|---|
| D-0699-2026 | Class II | Revitaderm Wound Care, First Aid Antiseptic Gel, Benzalkonium Chloride 0.1%) packaged as (a) 1.0 Fl… | Apr 8, 2026 |
| D-0694-2026 | Class II | TRIPENICOL S Antifungal Solution (Undecylenic Acid 25%), 1.25 FL OZ (37.5 mL) bottle, Manufactured… | Apr 8, 2026 |
| D-0692-2026 | Class I | Revitaderm Wound Care Gel, Benzalkonium Chloride 0.1%, packaged in 1.0 FL OZ (37 mL) bottle, shorter… | Apr 8, 2026 |
| D-0693-2026 | Class II | TRIFLUENT PHARMA TRIDERGEL Wound Care Gel, (Benzalkonium Chloride 0.1%), 1.0 fl oz, (29.6 mL) bottle… | Apr 8, 2026 |
| D-0697-2026 | Class II | TERPENICOL Antifungal Solution, (Undecylenic (10-Undecenoic) acid 25%), 1.0 Fl Oz (29.6 mL)… | Apr 8, 2026 |
| D-0695-2026 | Class II | TERPENICOL Antifungal Cream (Undecylenic Acid 13%), 1.0 oz (28 g) bottles, Manufactured By: Blaine… | Apr 8, 2026 |
| D-0698-2026 | Class II | Fungal Fusion ERADICATION Solution, Antifungal & Antimicrobial Kit. Contains, 1x2 oz bottle Fungal… | Apr 8, 2026 |
| D-0696-2026 | Class II | vite20 Antifungal Cream, (10% Undecylenic Acid), 0.54 OZ (15 g) bottle, Manufactured By: Blaine… | Apr 8, 2026 |
| D-0668-2022 | Class I | REVITADERM WOUND CARE GEL, (Benzalkonium Chloride in a gel containing transforming growth factor-b)… | Jan 25, 2022 |
Recent FDA inspections
| Date | Site | Product | Classification | FEI |
|---|---|---|---|---|
| Dec 22, 2025 | Santa Fe Springs, CA | Drugs | Official Action Indicated (OAI) | 3001744192 |
| Dec 15, 2023 | Santa Fe Springs, CA | Drugs | Official Action Indicated (OAI) | 3001744192 |
| Aug 24, 2021 | Santa Fe Springs, CA | Drugs | Official Action Indicated (OAI) | 3001744192 |
| Mar 24, 2016 | Santa Fe Springs, CA | Devices | No Action Indicated (NAI) | 3001744192 |
| Nov 16, 2015 | Santa Fe Springs, CA | Drugs | Voluntary Action Indicated (VAI) | 3001744192 |
| Apr 26, 2013 | Santa Fe Springs, CA | Devices | Voluntary Action Indicated (VAI) | 3001744192 |
| Jul 23, 2012 | Santa Fe Springs, CA | Drugs | Voluntary Action Indicated (VAI) | 3001744192 |
| Aug 12, 2010 | Santa Fe Springs, CA | Drugs | Voluntary Action Indicated (VAI) | 3001744192 |
- NAI
- No objectionable conditions or practices were found during the inspection.
- VAI
- Objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action.
- OAI
- Regulatory and/or administrative actions are recommended.
Compliance Actions
FDA's compliance actions data lists 1 compliance action under Blaine Labs Inc: warning letters, injunctions and seizures. None came from FDA's Center for Tobacco Products.
FDA-inspected facilities
| Facility | Location | Inspections | Latest |
|---|---|---|---|
| FEI 3001744192 | Santa Fe Springs, CA | 8 | Dec 22, 2025 |
Recent 510(k) clearances
| K-Number | Device | Date |
|---|---|---|
| K001608 | BLAINE SCARCARE PATCH | Jul 25, 2000 |
Blaine Labs Inc and the FDA: common questions
Has Blaine Labs Inc received an FDA warning letter?
Yes. FDA has issued 1 warning letter to Blaine Labs Inc. The most recent is dated May 5, 2020.
Has Blaine Labs Inc received an FDA Form 483?
FDA has not published a Form 483 for "Blaine Labs Inc" in its reading room. FDA publishes some Form 483s, not all of them.
When did the FDA last inspect Blaine Labs Inc?
The most recent FDA inspection on file ended Dec 22, 2025 at Santa Fe Springs, CA and was classified OAI. FDA has 8 inspections of Blaine Labs Inc on file, 3 of them classified OAI (official action indicated).
Has Blaine Labs Inc had an FDA recall?
Yes. Blaine Labs Inc has 9 FDA recalls on record, 2 of them Class I, the most serious class. The most recent started Apr 8, 2026.
Need more than this page shows? Ask about Blaine Labs Inc in Claude or ChatGPT and get every site's inspections, Form 483s, warning letters and import alerts, with a link to the FDA source for each record. The API key is free: no card.